Effect of Variceal Eradication on Portal Circulation (NCT04538209) | Clinical Trial Compass
UnknownNot Applicable
Effect of Variceal Eradication on Portal Circulation
52 participantsStarted 2021-01-15
Plain-language summary
Study the effect of variceal eradication on portal circulation, liver stiffness and Child-Pugh and MELD scores in patients with liver cirrhosis.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Age between 18 and 70 years old.
* Patient with documented liver cirrhosis undergoing either primary or secondary prophylactic variceal eradication.
* Liver cirrhosis with Child-Pugh score A and B.
Exclusion Criteria:
* • Age less than 18 years.
* Have contraindications to computed abdominal CT-angiography (e.g. allergy to all suitable contrast agents, renal failure).
* Patients with history of recent significant bleeding varices.
* Previous history of variceal ligation, sclerotherapy, and TIPS operation.
* Patients with isolated gastric varices.
* Patients with HCC or other malignancies.
* End-stage liver disease (Child score more than 9).
* Patients with malignant portal vein thrombosis.
* Patients with non-cirrhotic portal hypertension.
* Patients refuse to participate in the study.
What they're measuring
1
Study the effect of variceal eradication on portal circulation, liver stiffness and Child-Pugh and MELD scores in patients with liver cirrhosis.